Featured: Our Year in Review View Icon Oncology Group's Annual Research Report to learn more about our research portfolio.
Research across Icon Oncology Group is conducted through the Icon Cancer Centre (ICC) network.
ICC participates in a wide variety of clinical trials and research projects ranging from global, multi-centre, commercially-sponsored clinical trials of experimental agents, to studies developed by employees, doctors and visiting medical officers (VMOs).
This research aims to better understand, treat, or alleviate the diagnosis, symptoms or concerns of patients with cancer and blood disorders.
Research across the network facilitates:
As part of Icon Oncology Group, the ICC research network provides clinical trial sponsors with a comprehensive site management service, which allows access to multiple sites under a single ethics submission and governance structure including one contract, one budget and one indemnity. This increases efficiencies and improves study start-up timelines.
ICC is committed to the highest research standards and Icon Oncology Group’s dedicated Quality team ensures compliance with Good Clinical Practice (GCP), the TGA Clinical Trials Handbook, the NHMRC National Statement and all applicable national and international guidelines.
The Group’s Quality Management System, standard operating procedures (SOPs) and policies are implemented uniformly across each Icon Cancer Centre, ensuring standardised management of clinical trials. Icon provides ongoing comprehensive training and education to the research teams to ensure they continue to deliver consistently high standards.
As part of Icon Oncology Group, ICC is proud to hold GCSA Certification, the Global Quality Standard for Clinical Research Sites, and Gold-level Workforce Process Quality Certification (WPQC). Awarded by the International Accrediting Organisation for Clinical Research (IAOCR), the award builds on the Group’s milestone in 2024 when it became the first Australian clinical trial site network to achieve both certifications. In 2026 we are proud to successfully renew our GCSA Certification and progress from WPQC Silver to Gold.
Together, these internationally recognised certifications provide independent assurance of our commitment to quality, governance, operational excellence, workforce capability and participant-centred delivery of clinical trials and research.
They reinforce confidence that clinical trials and research conducted across the ICC network is delivered to globally recognised standards and supported by a culture of continuous improvement.
Learn more about our quality certifications and research excellence here.
Icon Oncology Group is proud to export Australian clinical expertise, alongside in-depth local knowledge and investment in innovative new technologies, to continue to deliver the best care possible, to as many people as possible, as close to home as possible across the globe.
Making a difference in reducing the global cancer burden is a collaborative effort and we are committed to continuing to extend our research partnerships and activities by partnering with new organisations who share common values in order to play a leading role in changing the face of cancer care.
We offer a number of benefits including:
If you would like to work with us to deliver national and international clinical research trials, please email [email protected]
IITs being conducted across the ICC research network are sponsored by Icon Cancer Foundation, a not-for-profit organisation whose mission is to promote, initiate and support clinical trials and research, striving towards a brighter future for cancer patients and communities. These unique investigator led trials, are in all oncology disciplines including medical oncology, haematology, radiation oncology, as well as pharmacy, nursing and medical physicist led trials. Icon Cancer Foundation are supported by the research team to develop, support and manage IITs across the global network.
ICC is proud to work with over 200 collaborators including Contract Research Organisations (CROs), commercial and non-commercial organisations (including the pharmaceutical industry, hospitals, and universities), industry vendors and service providers.
Our research team collaborated with COSA for their Annual Scientific Meeting through facilitation of the Pre- Conference Workshop ‘Tele-trials, the new norm?’. In line with the virtual theme the workshop was also made available via Icon Oncology Group’s digital platforms to participants around the world. This split presentation model provided opportunities to a wide variety of industry partners and participants to gain the most out of these resources in a platform that works for them.
ICC’s Research teams continue to collaborate with leading Queensland universities, UQ and QUT to provide work-integrated learning placements to undergraduate students interested in pursuing a career in research.
Icon Oncology Group is proud to have a global partnership with radiation oncology industry leaders, Varian Medical Systems (Varian), the cancer–care business of Siemens Healthineers. This partnership has extended to research with the intention to establish an improved process for identification, prioritisation and support of Icon Investigator-Initiated projects that align with Varian’s values and vision to further advance radiation therapy techniques.
ICC and Wesley Medical Research (in Queensland) have a longstanding relationship and are currently collaborating on a retrospective analysis of survival outcomes following autologous haematopoietic stem cell transplantation (ASCT) in the private sector. ICC performs the highest number of ASCT in Australasia with most transplants performed at The Wesley Hospital. This analysis will audit survival outcomes post-ASCT performed at ICC, including the development of a comprehensive database to ensure the high quality of clinical outcomes.
Icon Oncology Group is Australia’s largest dedicated cancer care provider and has expanded globally into New Zealand, Asia and the United Kingdom.
People from across Icon Oncology Group share their stories of success, career progression and being iconic.
At Icon Oncology Group, you’ll help change lives, every single day. In return for your passion, dedication and agility, we offer a workplace where you can.
Read the latest news and updates across Icon Oncology Group.